BB&T Investment Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$272K Buy
849
+71
+9% +$22.8K 0.05% 259
2017
Q3
$245K Sell
778
-96
-11% -$28.4K 0.05% 253
2017
Q2
$237K Sell
874
-49
-5% -$13K 0.06% 234
2017
Q1
$251K Buy
923
+87
+10% +$24.6K 0.1% 177
2016
Q4
$236K Buy
+836
New +$248K 0.17% 133

Other funds holding BIIB

BB&T Investment Services's BIIB Position: Q4 2017 in Review

BB&T Investment Services increased its Biogen (BIIB) stake by 9.1% in Q4 2017, buying an estimated $22.8K and bringing the position to 849 shares worth $272K. The position accounts for 0.05% of the portfolio, ranked #259.

BB&T Investment Services first reported a position in BIIB in Q4 2016 and has held it in 5 quarters since. 1,122 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

  • BB&T Investment Services held 849 shares of Biogen worth $272K as of Q4 2017.
  • BB&T Investment Services bought 71 Biogen shares in Q4 2017, an estimated $22.8K.
  • Biogen made up 0.05% of BB&T Investment Services's portfolio in Q4 2017, its #259 holding.
  • BB&T Investment Services first reported a position in Biogen in Q4 2016 and has held it in 5 quarters since.
  • 1,122 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.